Form 4: Rallybio Corp Director Liu Hui Acquires Options
SEC Form 4 Filing
Director Liu Hui acquired options to purchase 16,500 shares of Rallybio Corp stock on May 15, 2024.
Summary
- On May 15, 2024, Liu Hui, a director of Rallybio Corp, was granted options to purchase 16,500 shares of common stock.
- The options were granted under the company's 2021 Equity Incentive Plan with an exercise price of $1.91.
- The options vest on the earlier of May 15, 2025, or the date of the company's 2025 Annual Meeting of Stockholders and expire on May 15, 2034.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing an option grant. It doesn't contain information that would significantly sway investor sentiment positively or negatively.
Industry Context
This is a standard Form 4 filing, reflecting a transaction by a company insider. Option grants are a common form of executive compensation in the biotechnology industry.
Stakeholder Impact
- The option grant could potentially dilute existing shareholders if the options are exercised in the future.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of transaction: Liu Hui acquired options to purchase 16,500 shares of Rallybio Corp stock. |
| 05/15/2024 | Option grant date. |
| 05/15/2025 | Options vest on the earlier of this date or the date of the Company's 2025 Annual Meeting of Stockholders. |
| 05/15/2034 | Option expiration date. |
| 05/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.